3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and dihydroxyphenylalanine

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with dihydroxyphenylalanine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristow, LJ; Hutson, PH; Thorn, L; Tricklebank, MD1
Bai, X; Carroll, FI; Downing-Park, J; Mascarella, SW; Patrick, RL; Patrick, SL; Walker, JM; Weiser, SD1

Other Studies

2 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and dihydroxyphenylalanine

ArticleYear
Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: Amphetamine; Animals; Binding, Competitive; Corpus Striatum; Dihydroxyphenylalanine; Drug Interactions; Glycine; Male; Mice; Motor Activity; Neurons; Nucleus Accumbens; Pipecolic Acids; Piperazines; Receptors, N-Methyl-D-Aspartate

1994
Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands.
    European journal of pharmacology, 1995, Feb-24, Volume: 275, Issue:1

    Topics: Animals; Anticonvulsants; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Cyclazocine; Dihydroxyphenylalanine; Guanidines; Hydrazines; Male; Microinjections; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Substantia Nigra; Tyrosine 3-Monooxygenase

1995